Pulse Explorar nav.journalClub Debates Tendencias Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

Entrectinib and other ALK/TRK inhibitors for the treatment of neuroblastoma | Synapse

October 1, 2018Open Access

Entrectinib and other ALK/TRK inhibitors for the treatment of neuroblastoma

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

alterations in Phase I clinical trials in adults. Entrectinib's activity against both ALK and TRK proteins suggests a possible role in NB treatment, and it is currently under investigation in both pediatric and adult oncology patients.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Pacenta et al. (Mon,) studied this question.

synapsesocial.com/papers/6a00002cef8139f8ff777ce6 https://doi.org/https://doi.org/10.2147/dddt.s147384